{"entity":{"id":"nct04485286","kind":"trial","name":"Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury","aka":[],"tldr":"A phase 2 trial in pancreatic cancer, run by Massachusetts General Hospital, now recruiting.","summary":"Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury is a phase 2, interventional study registered as NCT04485286 by Massachusetts General Hospital, with a registry enrolment figure of 72 participants, started 2020-07-19 and due to reach its primary completion in 2027-05. Interventions recorded: [68Ga]CBP8. Conditions listed: Lung Cancer; Radiation Fibrosis; Radiation Induced Lung Injury; Pancreas Cancer. Primary outcome: Ability of [68Ga]CBP8 to detect collagen deposition in areas of radiation injury.. Pancreatic eligibility wording from the registry: \"Inclusion Criteria for pancreatic cancer subjects:\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT04485286","url":"https://clinicaltrials.gov/study/NCT04485286"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04485286","phase":"2","setting":"Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury","sponsor":"Massachusetts General Hospital","enrolled":72,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04485286/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}